(Q40199788)

English

Haloperidol and the significance of α-NE mediated control of a subpopulation of DA receptors for concepts such as supersensitivity and tolerance: A behavioral study on cats

scientific article published on December 18, 1978

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 September 2017

Haloperidol and the significance of α-NE mediated control of a subpopulation of DA receptors for concepts such as supersensitivity and tolerance: A behavioral study on cats (English)

reason for preferred rank

most precise value

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Haloperidol and the significance of alpha-NE mediated control of a subpopulation of DA receptors for concepts such as supersensitivity and tolerance: a behavioral study on cats (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A215864

13 January 2023

1 reference

based on heuristic

inferred from title

author name string

A. R. Cools

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A215864

13 January 2023

language of work or name

0 references

publication date

1 December 1978

1 reference

Europe PubMed Central

18 September 2017

18 December 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=215864

13 January 2023

full work available at URL

https://api.elsevier.com/content/article/PII:0024320578901716?httpAccept=text/xml

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

https://api.elsevier.com/content/article/PII:0024320578901716?httpAccept=text/plain

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

1 reference

Europe PubMed Central

18 September 2017

23

1 reference

Europe PubMed Central

18 September 2017

25

1 reference

Europe PubMed Central

18 September 2017

2475-2483

1 reference

Europe PubMed Central

18 September 2017

Influence of flupenthixol and flupenthixol-decanoate on methylphenidate and apomorphine-induced compulsive gnawing in mice

1

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Long-term effects of teflutixol on the synthesis and endogenous levels of mouse brain catecholamines

3

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Changes in dopamine synthesis rate in the supersensitivity phase after treatment with a single dose of neuroleptics

4

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Enhancement of methylphenidate-induced stereotypies by repeated administration of neuroleptis

5

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol

6

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

An experimental model of tardive dyskinesia

7

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Adrenergic Effect of Chronic Administration of Neuroleptics

8

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

9

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol

11

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Acute and subacute effects of neuroleptics on dopamine synthesis and release in the rat striatum

13

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administrations of neuroleptics

14

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration

15

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Excitation-mediating and inhibition-mediating dopamine-receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data

19

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Dopamine receptors: selective agonists and antagonists of functionally distinct types within the feline brain

20

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Neuroleptic antagonism of dyskinetic phenomena

21

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brain

22

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Evidence for dopamine receptors mediating sedation in the mouse brain

23

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: Evidence for two different mechanisms of action

24

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Two dopamine receptors: Supportive evidence with the rat rotational model

25

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Ontogenetic development of neostriatal dopamine receptors in the rat.

26

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors.

27

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Characterization of dopamine binding sites in standard preparations of brain synaptic membranes

28

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Possible dopaminergic pathway from substantia nigra to putamen.

31

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Molecular Pharmacology

33

14

403

author name string

Peroutka

publication date

1978

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Adaptive mechanisms of the noradrenergic cyclic AMP generating system in the limbic forebrain of the rat: adaptation to persistent changes in the availability of norepinephrine (NE)

34

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Modulation in the sensitivity of noradrenergic receptors in the CNS studied by the responsiveness of the cyclic AMP system

35

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Blockade by pimozide of a noradrenaline sensitive adenylate cyclase in the limbic forebrain: possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics

36

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

The noradrenergic cyclic AMP generating system in the limbic forebrain: Pharmacological characterization in vitro and possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics

37

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Effect of neuroleptics on endogenous norepinephrine in rat brain.

38

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Haloperidol blocks an alpha adrenergic receptor in the reticulo-cortical inhibitory input

39

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain

40

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol

41

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Further evidence for a change in central ?-adrenergic receptor sensitivity after withdrawal from long-term haloperidol treatment

42

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

43

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine

44

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain

48

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Identifiers

10.1016/0024-3205(78)90171-6

1 reference

Europe PubMed Central

18 September 2017

1 reference

Europe PubMed Central

18 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40199788&oldid=1810824093"